Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Molecular mechanisms and markers of vulvar squamous cell carcinoma progression.

2013/10/E/NZ5/00663

Keywords:

squamous cell vulvar carcinoma proteomics cancer progression cancer marker

Descriptors:

  • NZ5_3: Pathogenesis of human diseases
  • NZ5_5: Diagnostics in human diseases

Panel:

NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution :

Wydział Nauki o Zdrowiu, Warszawski Uniwersytet Medyczny, Wydział Nauki o Zdrowiu

woj. mazowieckie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr hab. Magdalena Kowalewska 

Number of co-investigators in the project: 10

Call: SONATA BIS 3 - announced on 2013-06-14

Amount awarded: 1 391 115 PLN

Project start date (Y-m-d): 2014-07-01

Project end date (Y-m-d): 2019-06-30

Project duration:: 60 months (the same as in the proposal)

Project status: Project settled

Information in the final report

  • Publication in academic press/journals (8)
  • Articles in post-conference publications (8)
  1. Somatic Mutation Profiling in Premalignant Lesions of Vulvar Squamous Cell Carcinoma
    Authors:
    Sebastian Zięba, Anne-Floor W Pouwer, Artur Kowalik, Kamil Zalewski, Natalia Rusetska, Elwira Bakuła-Zalewska, Janusz Kopczyński, Johanna M A Pijnenborg, Joanne A de Hullu, Magdalena Kowalewska
    Academic press:
    International Journal of Molecular Sciences (rok: 2020, tom: 21(14), strony: 45304), Wydawca: Multidisciplinary Digital Publishing Institute
    Status:
    Published
    DOI:
    10.3390/ijms21144880 - link to the publication
  2. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
    Authors:
    Zięba S, Kowalik A, Zalewski K, Rusetska N, Goryca K, Piaścik A, Misiek M, Bakuła-Zalewska E, Kopczyński J, Kowalski K, Radziszewski J, Bidziński M, Góźdź S, Kowalewska M.
    Academic press:
    Gynecol Oncol. (rok: 2018, tom: 150(3), strony: 552-561), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ygyno.2018.06.026. - link to the publication
  3. Inflammatory proteins HMGA2 and PRTN3 as drivers of vulvar squamous cell carcinoma progression
    Authors:
    Agnieszka Fatalska, Natalia Rusetska, Elwira Bakuła-Zalewska, Artur Kowalik, Sebastian Zięba, Agnieszka Wroblewska, Kamil Zalewski, Krzysztof Goryca, Dominik Domański, Magdalena Kowalewska
    Academic press:
    Cancers (rok: 2020, tom: brak, strony: brak), Wydawca: Multidisciplinary Digital Publishing Institute
    Status:
    Submitted
  4. Current approaches for avoiding the limitations of circulating tumor cells detection methods-implications for diagnosis and treatment of patients with solid tumors.
    Authors:
    Kowalik A, Kowalewska M, Góźdź S
    Academic press:
    Transl Res. (rok: 2017, tom: 185, strony: 58-84), Wydawca: Elsevier Inc.
    Status:
    Published
    DOI:
    10.1016/j.trsl.2017.04.002 - link to the publication
  5. Normalizers for microRNA quantification in plasma of patients with vulvar intraepithelial neoplasia lesions and vulvar carcinoma
    Authors:
    Zalewski K, Misiek M, Kowalik A, Bakuła-Zalewska E, Kopczyński J, Zielińska A, Bidziński M, Radziszewski J, Góźdź S, Kowalewska M.
    Academic press:
    Tumor Biol. (rok: 2017, tom: 39(11), strony: 45297), Wydawca: SAGE
    Status:
    Published
    DOI:
    10.1177/1010428317717140 - link to the publication
  6. Technetium-99m-based Radiopharmaceuticals in Sentinel Lymph Node Biopsy: Gynecologic Oncology Perspective.
    Authors:
    Zalewski K, Benke M, Mirocha B, Radziszewski J, Chechlinska M, Kowalewska M.
    Academic press:
    Curr Pharm Des. (rok: 2018, tom: 24(15), strony: 1652-1675), Wydawca: Bentham Science Publishers
    Status:
    Published
    DOI:
    10.1016/j.ygyno.2018.06.026 - link to the publication
  7. Genes, pathways and vulvar carcinoma - New insights from next-generation sequencing studies
    Authors:
    Sebastian Zięba, Magdalena Chechlińska, Artur Kowalik, Magdalena Kowalewska
    Academic press:
    Gynecologic Oncology (rok: 2020, tom: 158, strony: 498-506), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ygyno.2020.05.034 - link to the publication
  8. CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma
    Authors:
    Natalia Rusetska, Kamil Kowalski, Kamil Zalewski, Sebastian Zięba, Mariusz Bidziński, Krzysztof Goryca, Beata Kotowicz, Małgorzata Fuksiewicz, Janusz Kopczyński, Elwira Bakuła-Zalewska, Artur Kowalik, Magdalena Kowalewska
    Academic press:
    Journal of Clinical Pathology (rok: 2020, tom: brak, strony: brak), Wydawca: The BMJ
    Status:
    Submitted
  1. Protein markers of progression risk in patients with squamous cell vulvar carcinoma.
    Authors:
    •Kowalewska M, Fatalska A, Olędzki J, Goryca K, Bakuła-Zalewska E, Rusetska N, Kowalik A, Wroblewska A, Zalewski K, Domański D.
    Conference:
    EACR25 (rok: 2018, ), Wydawca: ESMO Open - BMJ Journals
    Data:
    konferencja 30.06-03.07.2018
    Status:
    Published
  2. Somatic mutations in vulvar squamous cell carcinoma and its premalignant lesions.
    Authors:
    Kowalik A, Zięba S, Rusetska N, Zalewski K, Piaścik A, Bakuła-Zalewska E, Kopczyński J, Kowalewska M.
    Conference:
    30th EORTC/AACR/NCI symposium (rok: 2018, ), Wydawca: European Journal of Cancer - Elsevier
    Data:
    konferencja 13-16.12.2018
    Status:
    Published
  3. HMGA2 and STAT-1 as Progression Markers in Squamous Cell Vulvar Carcinoma.
    Authors:
    Kowalewska M, Fatalska A, Olędzki J, Goryca K, Bakuła-Zalewska E, Rusetska N, Kowalik A, Misiek M, Wroblewska A, Zalewski K, Domański D.
    Conference:
    FIGO 2018 (rok: 2018, ), Wydawca: J Gynecol Obstet. - Wiley
    Data:
    konferencja 14-19.10.2018
    Status:
    Published
  4. CXCR4 as an independent prognostic factor for patients with early stage vulvar squamous cel carcinoma.
    Authors:
    Kowalewska M, Kowalski K, Zalewski K, Bakuła-Zalewska E, Goryca K, Bidzinski M, Radziszewski J
    Conference:
    16th Biennial Meeting of the International Gynecologic Cancer Society (rok: 2016, ), Wydawca: International Journal of Gynecological Cancer - LWW Journals
    Data:
    konferencja 29-31.10.2016
    Status:
    Published
  5. Identification of Protein Markers of Progression Risk in Patients with Squamous Cell Vulvar Carcinoma.
    Authors:
    Fatalska A, Domański D, Olędzki J, Goryca K, Kowalski K, Bakuła-Zalewska E, Kowalik A, Misiek M, Wroblewska A, Radziszewski J, Zalewski K, Bidzinski M, Kowalewska M
    Conference:
    20th Biennial Meeting of the European Society of Gynaecological Oncology (ESGO 2017) (rok: 2017, ), Wydawca: Wolters Kluver
    Data:
    konferencja 03-08.11.2017
    Status:
    Published
  6. Somatic mutation profiling in vulvar squamous cell carcinoma and its premalignant lesions.
    Authors:
    Zięba S, Pouwer AFW, Kowalik A, Zalewski K, Rusetska N, Bakuła-Zalewska E, Kopczyński J, Bulten J, Pijnenborg JMA, de Hullu JA, Kowalewska M.
    Conference:
    IGCS2018 (rok: 2018, ), Wydawca: IJGC - BMJ Journals
    Data:
    konferencja 14.09-16.09.2018
    Status:
    Published
  7. PI3K/AKT/MTOR Pathway as a Potential Target for Vulvar Squamous Cell Carcinoma Treatment.
    Authors:
    Zięba S, Kowalik A, Rusetska N, Zalewski K, Kowalski K, Bakuła-Zalewska E, Kopczyński J, Kowalewska M.
    Conference:
    IGCS2018 (rok: 2018, ), Wydawca: IJGC - BMJ Journals
    Data:
    konferencja 14.09-16.09.2018
    Status:
    Published
  8. Markers of progression risk in patients with squamous cell vulvar carcinoma.
    Authors:
    Fatalska A, Rusetska N, Bakuła-Zalewska E, Kowalik A, Wroblewska A, Zalewski K, Goryca K, Domański D, Kowalewska M.
    Conference:
    11th International Conference of Contemporary Oncology (rok: 2019, ), Wydawca: TERMEDIA Publishing House
    Data:
    konferencja 13-15.03.2019
    Status:
    Published